The BRAIN-CSVD study is a single-center prospective cohort study focusing on cerebral small vessel disease (CSVD).Patients enrolled in this research will undergo assessments for vascular risk factors, cognitive and other neurological functions, neuroimaging, and biomarkers. The study aims to explore imaging and biomarker predictors of CSVD progression, and the pathophysiological mechanisms of CSVD.
Age >= 18 years old;
Cerebral small vessel disease on MR imaging.
Cerebral infarction (except lacunar infarcts), cerebral hemorrhage, brain tumors, epilepsy, severe traumatic brain injury, or prior brain surgery;
Secondary white matter hyperintensities due to inflammatory, toxic causes and so on;
Contraindications to MRI.
Hospital-based patients
Cohort
Prospective
No intervention
Other interventionNo intervention
Cognitive function
Montreal Cognitive Assessment (MoCA) score, with a range of 0 to 30 points, where higher scores indicate better cognitive function.
Stroke
The rate of the patients with ischemic stroke or cerebral hemorrhagic stroke
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
